|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07J 43/00 | (2006.01) |
| A61P 25/14 | (2006.01) | ||
| A61K 31/57 | (2006.01) | ||
| A61K 31/58 | (2006.01) |
| (11) | Number of the document | 3705488 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20171670.1 |
| Date of filing the European patent application | 2015-05-29 | |
| (97) | Date of publication of the European application | 2020-09-09 |
| (45) | Date of publication and mention of the grant of the patent | 2022-08-03 |
| (46) | Date of publication of the claims translation | 2022-09-26 |
| (30) | Number | Date | Country code |
| PCT/CN2014/078820 | 2014-05-29 | WO |
| (72) |
BOTELLA, Gabriel Martinez , US
HARRISON, Boyd L. , US
ROBICHAUD, Albert Jean , US
SALITURO, Francesco G. , US
BERESIS, Richard Thomas , CN
|
| (73) |
Sage Therapeutics, Inc. ,
215 First Street, Cambridge, MA 02142,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Neuroaktyvūs steroidai, kompozicijos ir jų naudojimas |
| NEUROACTIVE STEROIDS, COMPOSITIONS AND USES THEREOF |
| Payment date | Validity (years) | Amount | |
| 2025-04-24 | 11 | 289.00 EUR |
| 2026-05-29 |